# Vitalhub Corp. (VHI.TO) fundamentals

Data as of 2026-11-04. TSX, Canada. Sector: Healthcare / Health Care Technology. Price C$7.79, market value C$493 million.

## Valuation
- **P/E (trailing): 64.9×** (5-yr avg 102.9×, 3-yr avg 107.8×). Vitalhub Corp. trades at 64.9× trailing earnings, well below its own five-year average of 102.9×: cheap by its own standards. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 24.0×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.36**. A PEG of 0.36 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 3.9×**. Each dollar of revenue is priced at 3.9×.
- **Price / book: 1.8×**. The shares trade at 1.8× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 15.8×**. Enterprise value is 15.8× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 4.2%** (5-yr avg 4.9%). Free cash flow equals 4.2% of the market value, in line with its five-year average of 4.9%.
- **Earnings yield: 1.5%**. The inverse of the P/E: 1.5% of the price is earned each year.

## Profitability
- **Gross margin: 80.3%**. Vitalhub Corp. keeps 80.3% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: 12.0%**. 12.0% of revenue is left after running the business.
- **Net margin: 5.6%**. 5.6% of each dollar of sales reaches the bottom line.
- **Return on equity: 2.3%**. 2.3% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 8.2%**. Return on all capital, debt included, is 8.2%.
- **Return on assets: 2.1%**. Each dollar of assets produces 2.1% of profit.

## Growth
- **Revenue growth (1 yr): 58.9%** (3-yr 39.7%/yr). Revenue grew 58.9% over the last year.
- **EPS growth (1 yr): 66.7%** (3-yr 49.4%/yr). Earnings per share rose 66.7%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): 10.7%/yr**. Free cash flow has compounded at 10.7% a year over three years, lagging earnings: check whether profits are turning into cash.

## Financial health
- **Debt to equity: 0.01**. Debt is 0.01 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Vitalhub Corp. holds more cash than debt.
- **Interest coverage: 122.4×**. Operating profit covers interest 122.4× over, a safe margin.
- **Current ratio: 2.40** (quick 2.40). Current assets cover the next year's liabilities 2.40 times.
- **Altman Z-score: 5.18**. A Z-score of 5.18 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Vitalhub Corp. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (11 analysts). 11 analysts cover Vitalhub Corp.; the consensus is buy, with an average price target of C$12.39 (+59% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -28.4%** (YTD -17.6%, 3-mo 14.0%). The shares are down 28.4% over twelve months including dividends.
- **From 52-week high: -28.4%** (20.6% above the low). Trading 28% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 57**. An RSI of 57 is neutral.
- **Beta (1 yr): 1.00** (volatility 40%). Beta of 1.00 against the S&P/TSX Composite: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=VHI.TO · Page: https://foliofundamentals.com/stocks/vhi.to

Not investment advice.